Name | PQR620 |
Synonyms | PQR620 PQR-620 PQR 620 2-Pyridinamine, 5-[4,6-bis(3-oxa-8-azabicyclo[3.2.1]oct-8-yl)-1,3,5-triazin-2-yl]-4-(difluoromethyl)- |
CAS | 1927857-56-4 |
Molecular Formula | C21H25F2N7O2 |
Molar Mass | 445.47 |
Density | 1.403±0.06 g/cm3(Predicted) |
Boling Point | 706.8±70.0 °C(Predicted) |
pKa | 5.12±0.10(Predicted) |
Storage Condition | -20℃ |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.245 ml | 11.224 ml | 22.448 ml |
5 mM | 0.449 ml | 2.245 ml | 4.49 ml |
10 mM | 0.224 ml | 1.122 ml | 2.245 ml |
5 mM | 0.045 ml | 0.224 ml | 0.449 ml |
biological activity | PQR620 is a novel, selective, orally bioavailable, dual Inhibitors of TORC1/2 with brain permeability. PQR620 had antitumor activity in the 56 lymphoma model assay, with a mean IC50 value of 250 nM at 72 hours of treatment. |
Target | Value |
TORC1 (Cell-based assay) | 250 nM |
TORC2 (Cell-free assay) | 250 nM |